<DOC>
	<DOCNO>NCT00676403</DOCNO>
	<brief_summary>To test effectiveness tolerability Lyrica various dose level RLS patient</brief_summary>
	<brief_title>Lyrica Dose Response Study With Restless Legs Syndrome ( RLS ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Moderate severe idiopathic RLS symptom occur predominantly even symptom interfere sleep onset maintenance Any secondary RLS require treatment daytime RLS symptom symptomatic neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>pregabalin , RLS , efficacy , safety</keyword>
</DOC>